Ann: Regeneus and AGC collaborate on Progenza in Japan, page-56

First 56 Last

Share
Profile

Follow
christophe

10,010 Posts.

103

02/01/17

15:22

Post #: 21637631
Share

Originally posted by christophe ↑

It seems AGC is really looking to expand it biopharmaceutical manufacturing arm.

It recently acquired a bio company for $60 billion Japanese yen.

AGC Signs Agreement for Acquisition of a Leading Biopharmaceutical CDMO, CMC Biologics

"AGC has been engaged in contract manufacturing business since the early 2000s. Its acquisition of CMC is part of AGC’s strategy to expand its biologics CDMO operations, complementing AGC’s current operations in Japan and Europe*note. The business integration with CMC will enable AGC to offer world-leading biologics CDMO API services, with a host of best-in-class technologies and manufacturing solutions by both mammalian and microbial operations for its global customer base.

Under its management policy, AGC plus , the AGC Group has designated its Life Science Business as one of its strategic areas. Through the business integration, the AGC Group will accelerate and expand its biopharmaceutical contract services business around the world."

I guess they have done that further now with Regeneus but they seem to be aggressively perusing this side of their business arm. I wonder what also will happen down the track with RGS and AGC??

Expand

That was from the AGC website. 20th December 2016 http://www.agc.com/english/news/20161220e.pdf

They don't seem scared to splash some cash and do good deals for the minnows.

A multi-national with ethics perhaps? Seem like a good company to do business with.

RGS Price at posting: 16.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

There are more pages in this discussion • 51 more messages in this thread...

First 56 Last

Add RGS (ASX) to my watchlist

Ann: Regeneus and AGC collaborate on Progenza in Japan, page-56

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Resolute shares bounce back as second payment made to Mali government to secure workers' release

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia